Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and lowers the price target from $19 to $16.
Oppenheimer Maintains Outperform on O’Reilly Automotive, Raises Price Target to $890
Oppenheimer analyst Brian Nagel maintains O'Reilly Automotive (NASDAQ:ORLY) with a Outperform and raises the price target from $800 to $890.